Qureshi Saeed A
Therapeutic Products Directorate, Health Products and Food Branch (A/L 2202C1), Health Canada, Ottawa K1A 0L2, Canada.
J Pharm Pharmacol. 2004 Sep;56(9):1135-41. doi: 10.1211/0022357044076.
Drug release characteristics of two amoxicillin capsule products, 250 and 500 mg strength each, have been described using USP Paddle and crescent-shaped spindles. Using the same spindles, dissolution experiments were conducted with USP disintegrating (prednisone) and non-disintegrating (salicylic acid) calibrator tablets. Dissolution tests were conducted at 50 and 25 rev min(-1) using USP Paddle and crescent-shaped spindles, respectively. In all cases, even with the higher 50 rev min(-1), lower percent drug release results were observed with the Paddle spindle than with the crescent-shaped spindle, which was operated at 25 rev min(-1). The observed lower dissolution for amoxicillin capsule products (< 36 vs > 87% at 30 min) and USP prednisone calibrator tablets (45.5 vs 99.8% at 30 min) with Paddle spindles appeared to occur because of the accumulation of the disintegrated material (cone formation) at the bottom, thus restricting product-medium interaction. Crescent-shaped spindles did not allow any accumulation of the product and provided improved interaction by mixing and stirring, and thus appeared to provide true drug dissolution characteristics of the products. On the other hand, in the case of non-disintegrating USP salicylic acid tablets (18.5 vs 24.4% at 30 min), lower results with Paddle spindles appeared to be because of stagnation of the tablets, which provided poor product-medium interaction for the surface touching the vessel surface. In this case, the crescent-shaped spindles moved the tablets at the base of the vessel, providing improved and efficient product-medium interaction, thus appearing to reflect truer dissolution characteristics of the tablets. The results highlight the possible artifacts of the USP Paddle spindle, which could lead to inaccurate characterization of drug release properties of test products. As reported previously, the artifacts of high variability in results and lack of relevance to product properties appeared to be related to poor mixing and variable hydrodynamics within a dissolution vessel. Results from this study provide further evidence that these artifacts might be addressed adequately using the crescent-shaped spindle, thus resulting in improved drug release as well as better product characterization.
已使用美国药典桨法和新月形搅拌桨描述了两种阿莫西林胶囊产品(每粒强度分别为250毫克和500毫克)的药物释放特性。使用相同的搅拌桨,对美国药典崩解型(泼尼松)和非崩解型(水杨酸)校正片进行了溶出实验。分别使用美国药典桨法和新月形搅拌桨在50转/分钟和25转/分钟下进行溶出试验。在所有情况下,即使转速较高为50转/分钟,使用桨形搅拌桨观察到的药物释放百分率结果也低于在25转/分钟下操作的新月形搅拌桨。观察到使用桨形搅拌桨时阿莫西林胶囊产品(30分钟时<36%对>87%)和美国药典泼尼松校正片(30分钟时45.5%对99.8%)的溶出较低,这似乎是由于崩解物料在底部堆积(形成圆锥),从而限制了产品与介质的相互作用。新月形搅拌桨不会使产品发生任何堆积,通过混合和搅拌提供了更好的相互作用,因此似乎能提供产品真正的药物溶解特性。另一方面,对于非崩解型美国药典水杨酸片(30分钟时18.5%对24.4%),使用桨形搅拌桨时结果较低似乎是由于片剂停滞,这使得与容器表面接触的片剂表面的产品与介质相互作用较差。在这种情况下,新月形搅拌桨使片剂在容器底部移动,提供了更好且高效的产品与介质相互作用,因此似乎能反映片剂更真实的溶解特性。结果突出了美国药典桨形搅拌桨可能存在的假象,这可能导致对测试产品药物释放特性的表征不准确。如先前报道,结果高度可变且与产品特性缺乏相关性的假象似乎与溶出容器内混合不良和流体动力学变化有关。本研究结果提供了进一步的证据,表明使用新月形搅拌桨可能足以解决这些假象,从而改善药物释放以及更好地表征产品。